<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> has been rarely reported in patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, a detailed description of its clinical course is lacking </plain></SENT>
<SENT sid="1" pm="."><plain>We report in detail the course of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> in two patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="2" pm="."><plain>Our experience suggests that it can be bilateral, can affect both eyes simultaneously, and can be recurrent </plain></SENT>
<SENT sid="3" pm="."><plain>The severity of the <z:hpo ids='HP_0000572'>visual loss</z:hpo> and its recovery can be very variable even in the same patient </plain></SENT>
<SENT sid="4" pm="."><plain>Early recognition of this entity and treatment with high-dose systemic <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> may limit the degree of permanent <z:hpo ids='HP_0000572'>visual loss</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>However, the optimal treatment has not been established </plain></SENT>
</text></document>